≡

Recombinant Dymeclin (DYM)

DMC; SMC; Dyggve-Melchior-Clausen syndrome protein

  • Product No.RPC438Hu01
  • Organism SpeciesHomo sapiens (Human) Same name, Different species.
  • SourceProkaryotic expression
  • HostE.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationMembrane, Cytoplasm, Golgi apparatus
  • Predicted Molecular Mass16.2kDa
  • Accurate Molecular Mass11kDa(Analysis of differences refer to the manual)
  • Residues & TagsSer546~Asp669 (Accession # Q7RTS9) with N-terminal His Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
  • Traits Freeze-dried powder
  • Purity> 97%
  • Isoelectric Point5.8
  • Applications Positive Control; Immunogen; SDS-PAGE; WB.
    If bio-activity of the protein is needed, please check active protein.
  • DownloadInstruction Manual
  • UOM 10µg50µg 200µg 1mg 5mg
  • FOB US$ 192  US$ 480  US$ 960  US$ 2880  US$ 7200 
    For more details, please contact local distributors!

SEQUENCE

USAGE

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPC438Hu01 Recombinant Dymeclin (DYM) Positive Control; Immunogen; SDS-PAGE; WB.
PAC438Hu01 Polyclonal Antibody to Dymeclin (DYM) WB; IHC; ICC; IP.
PAC438Hu02 Polyclonal Antibody to Dymeclin (DYM) WB; IHC; ICC; IP.
LAC438Hu71 Biotin-Linked Polyclonal Antibody to Dymeclin (DYM) WB; IHC; ICC.
MAC438Hu22 Monoclonal Antibody to Dymeclin (DYM) WB; IHC; ICC; IP.